Charles Schwab Investment Management Inc. Boosts Stake in Kymera Therapeutics, Inc. (NASDAQ:KYMR)
Charles Schwab Investment Management Inc. lifted its holdings in Kymera Therapeutics, Inc. (NASDAQ:KYMR – Free Report) by 5.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 387,187 shares of the company’s stock after purchasing an additional 20,346 shares during the quarter. […]
Charles Schwab Investment Management Inc. lifted its holdings in Kymera Therapeutics, Inc. (NASDAQ:KYMR – Free Report) by 5.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 387,187 shares of the company’s stock after purchasing an additional 20,346 shares during the quarter. […]
